Indication

Steatosis of liver

Steatosis of liver, also termed hepatic steatosis or fatty liver, is a clinicopathologic state characterized by the abnormal intracellular accumulation of lipids, primarily triglycerides, within the cytoplasm of hepatocytes. Read more about Steatosis of liver

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Steatosis of liver therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Steatosis of liver preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Steatosis of liver.

Steatosis of liver, also termed hepatic steatosis or fatty liver, is a clinicopathologic state characterized by the abnormal intracellular accumulation of lipids, primarily triglycerides, within the cytoplasm of hepatocytes.

It affects the hepatic system across diverse populations and is defined histologically when lipid droplets occupy at least 5% of hepatocytes, or radiologically by increased intrahepatic fat content.

Pathophysiologically, it stems from an imbalance between the hepatic uptake or de novo synthesis of fatty acids and their subsequent mitochondrial oxidation or export via very-low-density lipoproteins.

While often asymptomatic and reversible in its early stages, hepatic steatosis serves as the foundational hallmark for both metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease, carrying the potential to progress to steatohepatitis, fibrosis, and cirrhosis.

Personalize your experience

Follow Steatosis of liver and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it